Publication

Wang A, Ling Z, Yang Z, Kiela PR, Wang T, Wang C, Cao L, Geng F, Shen M, Ran X, et al. 2015. Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One. 10:e0126312. doi:10.1371/journal.pone.0126312.

Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea BD, Press OW, Constine LS, Barton KP, Friedberg JW, et al. 2015. Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313. Blood. 125:236–41. doi:10.1182/blood-2014-06-584623.

Savar A, Acin S, Gonzalez CL, El-Sawy T, Mejia O, Li Z, Esmaeli B, Lacy-Hulbert A, El-Naggar AK, McCarty JH, et al. 2015. Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment. Oncogene. 34:516–24. doi:10.1038/onc.2013.585.

Lu J, Liu C, Wang P, et al. "The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin." Biomaterials. 2015;62:176-87. PMCID: PMC4470812 PMID: 26057133. 2015.

Miller JA, Pappan K, Thompson PA, Want EJ, Siskos AP, Keun HC, Wulff J, Hu C, Lang JE, Chow H-HS. 2015. Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention. Cancer Prev Res (Phila). 8:86–93. doi:10.1158/1940-6207.CAPR-14-0100.

Martinez-Ariza G, Hulme C. 2015. Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer. Pharm Pat Anal. 4:387–402. doi:10.4155/ppa.15.20.

Ehsani S, Strigel R, Pettke E, Wilke L, Tevaarwerk A, Demartini W, Wisinski K. 2015. Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer. The Breast Journal. 2015; 21: 246-253. doi: 10.1111/tbj. 12396.

Nawrocki ST, Kelly KR, Smith PG, Keaton M, Carraway H, Sekeres MA, Maciejewski JP, Carew JS. 2015. The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine. Clin Cancer Res. 21:439–47. doi:10.1158/1078-0432.CCR-14-1960.

Davis AL, Qiao S, Lesson JL, de la Vega MR, Park SL, Seanez CM, Gokhale V, Cabello CM, Wondrak GT. 2015. The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells. J Biol Chem. 290:1623–38. doi:10.1074/jbc.M114.592626.

Laurila K, Ingram JC, Briehl MM, Trotter RT. 2015. Weaving the Web: Evaluation Strategies to Help Native-American Undergraduate Research Training Programs Navigate Students to Success. CURQ Web. 35:4–11.

Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. 2014. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies. AAPS PharmSciTech. 15:1574–87. doi:10.1208/s12249-014-0182-z.

Tao S, Wang S, Moghaddam SJ, Ooi A, Chapman E, Wong PK, Zhang DD. 2014. Oncogenic KRAS confers chemoresistance by upregulating NRF2. Cancer Res. 74:7430–41. doi:10.1158/0008-5472.CAN-14-1439.

Garcia DO, Thomson CA. 2014. Physical activity and cancer survivorship. Nutr Clin Pract. 29:768–79. doi:10.1177/0884533614551969.

Kim H, Lussier YA, Noh OK, Li H, Oh Y-T, Heo J. 2014. Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer. Radiother Oncol. 113:374–8. doi:10.1016/j.radonc.2014.11.007.

Hingle MD, Snyder AL, McKenzie NE, Thomson CA, Logan RA, Ellison EA, Koch SM, Harris RB. 2014. Effects of a short messaging service-based skin cancer prevention campaign in adolescents. Am J Prev Med. 47:617–23. doi:10.1016/j.amepre.2014.06.014.

Johnson GM, Chozinski TJ, Gallagher ES, Aspinwall CA, Miranda KM. 2014. Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors. Free Radic Biol Med. 76:299–307. doi:10.1016/j.freeradbiomed.2014.07.022.

Bell ML, Fiero M, Horton NJ, Hsu C-H. 2014. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 14:118. doi:10.1186/1471-2288-14-118.

Pries AR, Secomb TW. 2014. Making microvascular networks work: angiogenesis, remodeling, and pruning. Physiology (Bethesda). 29:446–55. doi:10.1152/physiol.00012.2014.

Sharma S, Wongpalee SP, Vashisht A, Wohlschlegel JA, Black DL. 2014. Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly. Genes Dev. 28:2518–31. doi:10.1101/gad.248625.114.

Algotar AM, Behnejad R, Stratton MS, Stratton SP. 2014. Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancer. Cancer Epidemiol Biomarkers Prev. 23:2196–8. doi:10.1158/1055-9965.EPI-14-0605.

Centuori SM, Martinez JD. 2014. Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer. Dig Dis Sci. 59:2367–80. doi:10.1007/s10620-014-3190-7.

Akam EA, Chang TM, Astashkin AV, Tomat E. 2014. Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators. Metallomics. 6:1905–12. doi:10.1039/c4mt00153b.

Bell ML, Fairclough DL. 2014. Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Stat Methods Med Res. 23:440–59. doi:10.1177/0962280213476378.

Singh N, Vasam G, Pawar R, Jarajapu YPR. 2014. Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes. J Sex Med. 11:2153–63. doi:10.1111/jsm.12620.

Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, et al. 2014. Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence. Cancer Prev Res (Phila). 7:896–905. doi:10.1158/1940-6207.CAPR-13-0408.